Assessing Vaccine Safety for Young People With Rheumatic Disorders

The effect of rheumatic disease on vaccine safety in children was examined.

Rheumatic Manifestations of HCV: New Treatment Options

Patients with HCV are at risk for several extrahepatic sequelae. Find out what they are, and the new treatment options for managing HCV in RA.

OMERACT Assessment Effectively Identifies Rheumatoid Arthritis Flares

Preliminary findings suggest that the OMERACT flare assessment tool is effective for identifying RA flares, with high agreement between providers and patients on flare status.

Improved Diagnosis of CVD in Patients With RA: Expert Insights

Cardiac magnetic resonance imaging can detect structural and functional cardiovascular abnormalities in the very early preclinical stage.

Rheumatoid Arthritis and Asthma: Is There a Link?

Rheumatoid arthritis and asthma have a strong association that could enable earlier disease recognition and improved treatments.

ICER Concludes Targeted Immunomodulators Are Overpriced: Advocacy Organizations Express Concern

ICER found TIMs to be efficacious overall but did not find them to be cost-effective.

Bi-Directional Links Between Rheumatoid Arthritis and Periodontal Disease

Periodontal disease may be the main precipitating factor in the development of rheumatoid arthritis by fostering the environment for multiple destructive mechanisms that attack synovial ...

JAK/STAT Inhibitors: A New Treatment Target for Rheumatoid Arthritis

Janus kinase and signal transducers and activators of transcription inhibitors represent promising treatment targets in RA.

Cytomegalovirus Connection With Rheumatoid Arthritis Cardiovascular Disease Risk: An Expert Interview

Florian Kern, deputy director of research at Brighton and Sussex Medical School in the United Kingdom, discusses his recently published review wherein he and his ...

Rheumatoid Arthritis and Omega-3 Fatty Acids: Decades of Studies Yield No Clear Answer

Researchers have long been interested in whether omega-3 supplements can improve rheumatoid arthritis symptoms.

Latest News

Reactivation Rate of Hepatitis B in Inflammatory Arthritis Tx With DMARDs

Reactivation Rate of Hepatitis B in Inflammatory Arthritis Tx With DMARDs

HBV reactivation rates were lower among all chronic HBV infection patients on antiviral prophylaxis, regardless of whether they were receiving TNF inhibitors.

When Other Disease-Modifying Antirheumatic Drugs Don't Work, Try Sirukumab

When Other Disease-Modifying Antirheumatic Drugs Don't Work, Try Sirukumab

For patients with active rheumatoid arthritis who are not responding to DMARDs, sirukumab may represent a safe and effective treatment.

COBRA vs COBRA-Light for Rheumatoid Arthritis: Assessing Efficacy, Safety

COBRA vs COBRA-Light for Rheumatoid Arthritis: Assessing Efficacy, Safety

Patients recently diagnosed with rheumatoid arthritis showed similar efficacy and safety outcomes during a 4-year follow-up period after receiving treatment with COBRA-light or COBRA therapy.

Live Zoster Vaccination Safe in RA Prior to Tofacitinib Initiation

Live Zoster Vaccination Safe in RA Prior to Tofacitinib Initiation

Herpes zoster vaccine shown to be safe in patients with rheumatoid arthritis.

SB4 vs Etanercept in Rheumatoid Arthritis: Long-term Efficacy and Safety

SB4 vs Etanercept in Rheumatoid Arthritis: Long-term Efficacy and Safety

Switching from ETN to SB4 was not associated with a loss of efficacy, a rise in TEAEs, or an increase in immunogenicity.

Minimal Transfer of Certolizumab Pegol to Mature Breast Milk

Minimal Transfer of Certolizumab Pegol to Mature Breast Milk

The first lactation study of its kind evaluated whether a biologic drug is transferred into mature breast milk

RA: Serious Infection Event Rate Comparable With Tofacitinib vs Baricitinib

RA: Serious Infection Event Rate Comparable With Tofacitinib vs Baricitinib

The risk for serious infection events in rheumatoid arthritis with tofacitinib is compatible to risk rates of biologic disease-modifying antirheumatic drugs and baricitinib.

Tocilizumab Associated With Improved Anemia Markers in Patients With Rheumatoid Arthritis

Tocilizumab Associated With Improved Anemia Markers in Patients With Rheumatoid Arthritis

Other biologic DMARDs were not associated with any significant clinically meaningful increase in Hb and Hct levels.

Differences in RA Treatment Goals Between Patients and Healthcare Providers

Differences in RA Treatment Goals Between Patients and Healthcare Providers

A physician- and patient-based survey revealed differences in treatment goals, patient concerns, and more.

FDA Approval of Biosimilar Cyltezo for Multiple Indications

FDA Approval of Biosimilar Cyltezo for Multiple Indications

Cyltezo subcutaneous injection has been approved by the FDA.

Latest Slideshows

Alcohol Use: Surveying Effects on the Body's Major Systems

Alcohol Use: Surveying Effects on the Body's Major Systems

The effects of alcohol on the body's systems are examined here, with both damaging and potentially protective effects being explored. ...

Ten Unusually Specific ICD-10 Codes

Ten Unusually Specific ICD-10 Codes

With nearly 70,000 ICD-10 diagnosis codes available to clinicians, things are bound to get interesting.

Role of Vitamin D in Rheumatoid Arthritis Pathogenesis

Role of Vitamin D in Rheumatoid Arthritis Pathogenesis

Increasing evidence indicates serum vitamin D levels and polymorphisms in enzymes involved in vitamin D metabolism can affect the risk ...

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general ...

Examining Patient-Reported Outcomes in Rheumatoid Arthritis

Examining Patient-Reported Outcomes in Rheumatoid Arthritis

Validation of a patient-report outcome instrument as an effective independent tool for measuring disease activity and treatment response may one ...

Sign Up for Free e-newsletters